Dual glucagon recognition by pancreatic β-cells via glucagon and glucagon-like peptide 1 receptors

Diabetes

Volumn 47, Issue 1, 1998, Pages 66-72

  Moens, Karen ^a   Flamez, Daisy ^a   Van Schravendijk, Chris ^a   Ling, Zhidong ^a   Pipeleers, Daniel ^a   Schuit, Frans ^a  

^a DIABETES RESEARCH CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; DES HIS 1 GLUCOSE 9 GLUCAGON AMIDE; EXENDIN; GLUCAGON; GLUCAGON DERIVATIVE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON RECEPTOR ANTAGONIST; GLUCOSE; INSULIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; BINDING SITE; CONTROLLED STUDY; GLUCAGON RELEASE; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; MOLECULAR RECOGNITION; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

EID: 0031965605     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.47.1.66     Document Type: Article

References (46)

1. Pipeleers D: The biosociology of pancreatic B cells. Diabetologia 30:277-291, 1987
2. 2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol Rev 67:1185-1248, 1987
3. Schuit FC: Factors determining the glucose sensitivity and glucose responsiveness of pancreatic B cells. Horm Res 46:99-106, 1996
4. Henquin J: Cell biology of insulin secretion. In Joslin's Diabetes Mellitus. Kahn CR, Weir GC, Eds. Philadelphia, Lea & Febiger, 1994, p. 56-78
5. Pipeleers D, in't Veld P, Maes E, Van de Winkel M: Glucose-induced insulin release depends on functional cooperation between islet cells. Proc Natl Acad Sci USA 79:7322-7325, 1982
6. Pipeleers DG, Schuit FC, in't Veld P, Maes E, Hooghe-Peters EL, Van De Winkel M, Gepts W: Interplay of nutrients and hormones in the regulation of insulin release. Endocrinology 117:824-833, 1985
7. Wang JL, Corbett JA, Marshall CA, McDaniel ML: Glucose-induced insulin secretion from purified β-cells. J Biol Chem 268:7785-7791, 1993
8. Weir GC, Mojsov S, Hendrick GK, Habener JF: Glucagonlike peptide I (7-37) actions on endocrine pancreas. Diabetes 38:338-342, 1989
9. Creutzfeldt W: The incretin concept today. Diabetologia 16:75-85, 1979
10. Yada T, Sakurada M, Ihida K, Nakata M, Murata F, Arimura A, Kikuchi M: Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet β-cells. J Biol Chem 269:1290-1293, 1994
11. Kato I, Suzuki Y, Akabane A, Yonekura H, Tanaka O, Kondo H, Takasawa S, Yoshimoto T, Okamoto H: Transgenic mice overexpressing human vasoactive intestinal peptide (VIP) gene in pancreatic β cells: evidence for improved glucose tolerance and enhanced insulin secretion by VIP and PHM-27 in vivo. J Biol Chem 269:21223-21228, 1994
12. Thorens B, Waeber G: Glucagon-like peptide-I and the control of insulin secretion in the normal state and in NIDDM. Diabetes 42:1219-1225, 1993
13. Fehmann HC, Göke R, Göke B: Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocr Rev 16:390-410, 1995
14. Thorens B: Expression cloning of the pancreatic β cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc Natl Acad Sci USA 89:8641-8045, 1992
15. Gremlich S, Porret A, Hani EH, Cherif D, Vionnet N, Froguel P, Thorens B: Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor. Diabetes 44:1202-1208, 1995
16. Usdin TB, Mezey E, Button DC, Brownstein MJ, Bonner TI: Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology 133:2861-2870, 1993
17. Moens K, Heimberg H, Flamez D, Huypens P, Quartier E, Ling Z, Pipeleers D, Gremlich S, Thorens B, Schuit F: Expression and functional activity of glucagon, glueagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells. Diabetes 45:257-261, 1996
18. Göke R, Fehmann H-C, Linn T, Schmidt H, Krause M, Eng J, Göke B: Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting β-cells. J Biol Chem 268:19650-19655, 1993
19. Kolligs F, Fehmann H-C, Göke R, Göke B: Reduction of the incretin effect in rats by the glucagon-like peptide I receptor antagonist exendin (9-39) amide. Diabetes 44:16-19, 1995
20. Scrocchi LA, Brown TJ, Maclusky N, Brubaker PL, Auerbach AB, Joyner AL, Drucker DJ: Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med 2:1254-1258, 1996
21. Samols E, Marri G, Marks V: Promotion of insulin secretion by glucagon. Lancet ii:415-416, 1965
22. Van Schravendijk CFH, Foriers A, Hooghe-Peters EL, Rogers V, De Meyts P, Sodoyez JC, Pipeleers DG: Pancreatic hormone receptors on islet cells. Endocrinology 117:841-848, 1986
23. Schuit PC, Pipeleers DG: Regulation of adenosine 3′,5′-monophosphate levels in the pancreatic B cell. Endocrinology 117:834-840, 1985
24. Kofod H, Adelhorst K, Christensen LB, Fuhlendorff J, Godtfredsen SE, Kirk O, Lundgren K: Beta-cells do not have glucagon receptors but GLP-1 receptors! Digestion 54:346-347, 1993
25. Kieffer TJ, Heller RS, Unson CG, Weir GC, Habener JF: Distribution of glucagon receptors on hormone-specific endocrine cells of rat pancreatic islets. Endocrinology 137:5119-5125, 1996
26. Marie J, Boissard C, Skoglund G, Rosselin G, Breant B: Glucagon acts through its own receptors in the presence of functional glucagon-like peptide-1 receptors on hamster insulinoma. Endocrinology 137:4108-4114, 1996
27. Kawai K, Yokota C, Ohashi S, Watanabe Y, Yamashita K: Evidence that glucagon stimulates insulin secretion through its own receptor in rats. Diabetologia 38:274-276, 1995
28. Abrahamsen N, Nishimura E: Regulation of glucagon and glucagon-like peptide-1 receptor messenger ribonucleic acid expression in cultured rat pancreatic islets by glucose, cyclic adenosine 3′,5′-monophosphate, and gluco-corticoids. Endocrinology 136:1572-1578, 1995
29. Hanssen LH, Abrahamsen N, Nishimura E: Glucagon receptor mRNA distribution in rat tissues. Peptides 16:1163-1166, 1995
30. Campos RV, Lee YC, Drucker DJ: Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. Endocrinology 134:2156-2164, 1994
31. Fehlmann M, Morin O, Kitabgi P, Freychet P: Insulin and glucagon receptors of isolated rat hepatocytes: comparison between hormone binding and amino acid transport stimulation. Endocrinology 109:253-261, 1981
32. Unson CG, Andreu D, Gurzenda EM, Merrifield RB: Synthetic peptide antagonists of glucagon. Proc Natl Acad Sci USA 84:4083-4087, 1987
33. Rogiers V, Paeme G, Vercruysse A, Bouwens L: Procycline metabolism in isolated rat liver cells. In Pharmacological, Morphological and Physiological Aspects of Liver Aging. Van Bezooyen CFA, Ed. Eurage, Rijswijk, 1984, p. 155-163
34. Pipeleers DG, in't Veld P, Van De Winkel M, Maes E, Schuit FC, Gepts W: A new in vitro model for the study of pancreatic A and B cells. Endocrinology 117:806-816, 1985
35. Ling Z, Hannaert JC, Pipeleers D: Effects of nutrients, hormones and serum on survival of rat islet beta cells in culture. Diabetologia 37:15-21, 1994
36. Semakula C, Vandewalle CL, Van Schravendijk CFH, Sodoyez J, Schuit FC, Foriers A, Falorni A, Craen M, Decraene P, Pipeleers DO, Gorus FK, the Belgian Diabetes Registry: Abnormal circulating pancreatic enzyme activities in more than twenty-five percent of recent-onset insulin-dependent diabetic patients: association of hyperlipasemia with high-titer islet cell antibodies. Pancreas 12:321-333, 1996
37. Van Schravendijk CFH, Kiekens R, Pipeleers DG: Pancreatic β cell heterogeneity in glucose-induced insulin secretion. J Biol Chem 267:21344-21348, 1992
38. 2 identifies glucagon antagonists from weak partial agonists/antagonists. Endocrinology 137:3316-3322, 1996
39. Pipeleers DG, Schuit FC, Van Schravendijk CFH, Van De Winkel M: Interplay of nutrients and hormones in the regulation of glucagon release. Endocrinology 117:817-823, 1985
40. Kreymann B, Ghatei MA, Williams G, Bloom SR: Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet ii:1300-1305, 1987
41. Bonner-Weir S, Orci L: New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 31:883-889, 1982
42. Hager J, Hansen L, Vaisse C, Vionnet N, Philippi A, Poller W, Velho G, Carcassi C, Contu L, Julier C, Cambien F, Passa P, Lathrop M, Kindsvogel W, Demenais F, Nishimura E, Froguel P: A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus. Nat Gen 9:299-304, 1995
43. Hansen LH, Abrahamsen N, Hager J, Jelinek L, Kindsvogel W, Froguel P, Nishimura E: The Gly40Ser mutation in the human glucagon receptor gene associated with NIDDM results in a receptor with reduced sensitivity to glucagon. Diabetes 45:725-730, 1996
44. Harbeck MC, Louie DC, Howland J, Wolf BA, Rothenberg PL: Expression of insulin receptor mRNA and insulin receptor substrate 1 in pancreatic islet β-cells. Diabetes 45:711-717, 1996
45. Van Schravendijk CFH, Foriers A, Van den Brande JL, Pipeleers DG: Evidence for the presence of type I insulin-like growth factor receptors on rat pancreatic A and B cells. Endocrinology 121:1784-1788, 1987
46. Schuit FC, Derde MP, Pipeleers DG: Sensitivity of pancreatic A and B cells to somatostatin. Diabetologia 32:207-212, 1989